Open-House Procedure for Biomarker-Based Treatment Strategies in Breast Cancer
Open-House-Verfahren biomarkerbasierte Behandlungsstrategien bei Brustkrebs
Germany
Contract
BuyerAOK Bayern - Die Gesundheitskasse
TypeServices
Estimated valuevalue not published
Published29 February 2020
CategoryHealth & social work · CPV 85000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| ratiopharm GmbH | 56 | 2014–2023 |
| Hexal AG · Holzkirchen | 46 | 2011–2022 |
| Aliud Pharma GmbH · Laichingen | 45 | 2011–2023 |
| Haemato Pharm GmbH · Schönefeld | 43 | 2014–2022 |
| Orifarm GmbH · Leverkusen | 39 | 2018–2023 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
20192
20209
20219
20224
202311
202523
20263
Who knows the rhythm prepares instead of reacting.
1288
days until the deadline — Thursday 28 February at 10:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →